Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy alternatives remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/us-treasury-department-appoints-galaxy-digitals-tyler-williams-for-digital-assets/